Featured Editorial
-
From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
12/3/2025
Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.
-
How To Identify Patient-Centric Risks In The TMF With AI And Automation
11/20/2025
Discover how AI and automation tools transform how we manage TMF content when it comes to identifying patient-centric risks.
-
How The TMF Demonstrates Patient Safety And Rights In DCTs
11/19/2025
The TMF is not just a compliance tool, says consultant Donatella Ballerini. It's a window into how well we are protecting patients.
-
Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
11/18/2025
Discover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.
-
How AI Is Rewriting The Future Of TMF And Clinical Quality
10/29/2025
Discover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.
-
Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
10/28/2025
Explore some of the common pitfalls witnessed in healthcare environments, as well as guidance for implementing a penetration testing program.
-
Penetration Testing In Healthcare: HIPAA And GDPR Requirements
10/27/2025
Learn about penetration testing requirements in the healthcare environment, including clinical research, according to HIPAA and GDPR.
-
FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
10/23/2025
As the FDA, MHRA, and EMA release draft frameworks on externally controlled trials, sponsors face differing expectations. The U.K. leans pragmatic, the U.S. remains cautious, and Europe’s guidance is still evolving — leaving global trial planners to navigate regulatory gray zones.
-
What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
10/8/2025
During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.
-
SCDM 2025: Practical Advice From Global Regulators — Including The FDA
10/6/2025
Discover what regulators from around the world, including the FDA, think should be top of mind for clinical data managers.